Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Salarius Pharmaceuticals, Inc (SLRX)  
$0.61 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 2,280,000
Market Cap: 1.38(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6068 - $0.6068
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Salarius Pharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s pipeline consists of two compounds: seclidemstat (SP-2577), a small molecular inhibitor and SP-3164, a small molecular protein degrader. SP-2577 is a small-molecule lysine specific demethylase 1 (LSD1) inhibitor with a scaffold. LSD1 is an enzyme that is, in part, responsible for epigenetic regulation of genes that support cancer growth. SP-3164 is a cereblon binding molecular glue. SP-3164 degrades transcription factors IKZF1 and IKZF3, along with other proteins, resulting in both direct anti-cancer activity and immune-modulating properties. SP-3164 has activity in both hematologic and solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 191,653
Total Buy Value $0 $0 $0 $35,178
Total People Bought 0 0 0 6
Total Buy Transactions 0 0 0 7
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 156
  Page 2 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Arthur David J. Chief Executive Officer   •       •      –    2022-03-03 4 B $0.39 $54,540 D/D 139,488 249,674 2.81     -
   Rosenblum Mark J Exec VP Finance, CFO   •       –      –    2021-11-03 4 A $0.72 $5,591 D/D 7,787 34,073     -
   Arthur David J. Chief Executive Officer   •       •      –    2021-11-03 4 A $0.72 $5,700 D/D 7,939 110,186     -
   Arthur David J. Chief Executive Officer   •       •      –    2021-08-17 4 B $0.89 $3,582 I/I 4,000 102,247 2.58     -
   Hanish Arnold C Director   –       •      –    2021-08-10 4 B $0.88 $6,167 I/I 7,000 18,350 2.1     -
   Rosenblum Mark J Exec VP Finance, CFO   •       –      –    2021-05-03 4 A $0.57 $5,422 D/D 9,563 26,286     -
   Arthur David J. Chief Executive Officer   •       •      –    2021-05-03 4 A $0.57 $5,569 D/D 9,822 96,247     -
   Arthur David J. Chief Executive Officer   •       •      –    2020-11-03 4 A $0.56 $2,737 D/D 4,879 86,425     -
   Rosenblum Mark J Exec VP Finance, CFO   •       –      –    2020-11-03 4 A $0.56 $2,650 D/D 4,723 16,723     -
   Hanish Arnold C Director   –       •      –    2020-08-21 4/A B $0.98 $3,920 I/I 4,000 11,350 2.1     -
   Hanish Arnold C Director   –       •      –    2020-08-21 4 B $0.98 $3,920 D/D 4,000 11,350 2.31     -
   Arthur David J. Chief Executive Officer   •       •      –    2020-08-19 4 B $1.01 $2,020 I/I 2,000 2,000 2.58     -
   Rosenblum Mark J Exec VP Finance, CFO   •       –      –    2020-08-17 4 B $1.00 $5,000 D/D 5,000 12,000 2.74     -
   Rosenblum Mark J Exec VP Finance, CFO   •       –      –    2020-02-19 4 B $0.95 $1,900 D/D 2,000 7,000 2.66     -
   Jordan Scott Chief Business Officer   •       –      –    2020-02-18 4 B $0.90 $10,170 D/D 11,300 31,609 2.74     -
   Rosenblum Mark J Exec VP Finance, CFO   •       –      –    2020-02-13 4 B $0.86 $4,295 D/D 5,000 5,000 2.66     -
   Hanish Arnold C Director   –       •      –    2020-02-11 4/A B $1.15 $5,003 I/I 4,350 7,350 2.1     -
   Mcvicar William K. Director   –       •      –    2020-02-11 4 B $1.15 $10,005 D/D 8,700 8,700 2.39     -
   Arthur David J. Chief Executive Officer   •       •      –    2020-02-11 4 B $1.15 $2,501 D/D 2,175 81,546 2.73     -
   Burleson Tess Director   –       •      –    2020-02-11 4 B $1.15 $5,003 D/D 4,350 4,350 2.39     -
   Mccreedy Bruce J Jr. Director   –       •      –    2020-02-11 4 B $1.15 $10,005 D/D 8,700 8,700 2.39     -
   Hanish Arnold C Director   –       •      –    2020-02-11 4 B $1.15 $5,003 D/D 4,350 7,350 2.39     -
   Northrup Jonathan P Director   –       •      –    2020-02-11 4 B $1.15 $10,005 D/D 8,700 352,713 2.39     -
   Hanish Arnold C Director   –       •      –    2019-11-25 4/A B $3.59 $10,770 I/I 3,000 3,000 2.1     -
   Hanish Arnold C Director   –       •      –    2019-11-25 4/A B $3.59 $10,770 D/D 3,000 3,000 2.39     -
  156 Records found
  1  2  3  4  5  6  7   
  Page 2 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us